Advancing Healthcare Innovation: Segmed’s Impact at Scale

Segmed has been advancing and conquering milestones: building a nationwide, privacy-first imaging data network spanning all 50 U.S. states, supporting more than 150 million imaging studies, and enabling over 35 FDA-cleared AI technologies.

Our new Impact Report, Advancing Healthcare Innovation with Segmed, captures what this progress looks like in practice, across customers, research, healthcare providers, and the broader ecosystem.

From Vision to Infrastructure

Segmed was founded with a clear mission: unlock high-quality, diverse medical imaging data for research and innovation, without compromising patient privacy.

Today, that vision has become infrastructure:
‍

• A network covering all 50 U.S. states

• 150M+ de-identified imaging studies

• Support for 35+ FDA-cleared AI solutions

• Customers across 20 countries

• Industry-leading certifications, including ISO27001, SOC 2 Type II, HIPAA Safe Harbor, and Expert Determination

This foundation enables healthcare innovators to build AI that is not only powerful, but representative, reliable, and regulatory-ready.

‍

Real-World Impact Across the Ecosystem

Segmed’s impact spans the full innovation lifecycle:

AI & Product Development
From traditional AI validation to large-scale foundation models, Segmed datasets power training, validation, and FDA submissions across modalities including CT, MRI, X-ray, PET, pathology, and EHR-linked data.

Real-World Evidence & Clinical Research
Researchers leverage longitudinal, multimodal datasets to develop predictive imaging biomarkers, external control arms, and outcome-driven insights, accelerating discovery while preserving rigor.

Healthcare Equity & Representation
Before Segmed, deep learning models were often trained on data from just a few states. Today, AI models can be trained on patient cohorts from all U.S. states, improving generalizability and equity.

Trusted by Industry and Academia

Segmed partners with leading enterprises, startups, and academic institutions, supporting global research, peer-reviewed publications, and invited presentations at major conferences including RSNA, ECR, SIIM, and PMWC. Our customer feedback consistently highlights:
‍

• Speed and scale of data access

• Legal and regulatory simplicity

• Diversity and clinical relevance of datasets

• Professionalism and trust

What’s Next

The Impact Report also outlines Segmed’s next chapter:
‍

• Expansion into multimodal data (EHR, pathology, molecular)

• AI-driven insights layered on imaging data

• Deeper engagement with pharma and life sciences

• Continued investment in governance, privacy, and trust

Healthcare innovation is no longer constrained by ambition: it’s constrained by access. Segmed is building the infrastructure to remove that barrier.

‍Download and read the full Impact Report to explore the data, partnerships, and outcomes shaping the future of healthcare innovation.

‍